Why SPECCRO? Pharma R&D has entered an era of diminishing returns—despite massive investments, nearly 90% of drug candidates still fail in clinical trials, often due to poor efficacy or undetected toxicity. Animal models, long the standard in preclinical testing, fall short in mimicking human biolo... Read more
This company has no offices yet